blinatumomab,ponatinib
otsuka,amgen,takeda,astellas,incyte
['blina ', 'ponatinib', 'ph+ all']
ponatinib+blina in frontline ph+ all needs a randomized trial but what would you even put it against and is it practice changing already. i think yes. #ash22
Focused on improving outcomes and life for young people with cancer #AYACSM
IM/Peds @umichmedicine, Ped/Adult Oncology @OHSUKnight, Assist Prof @UCCancerCenter